MARKET

BSTC

BSTC

Biospecifics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

59.66
-0.30
-0.50%
After Hours: 59.66 0 0.00% 16:00 12/13 EST
OPEN
60.38
PREV CLOSE
59.96
HIGH
60.54
LOW
59.10
VOLUME
34.51K
TURNOVER
--
52 WEEK HIGH
73.31
52 WEEK LOW
45.81
MARKET CAP
438.07M
P/E (TTM)
18.82
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BSTC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BSTC News

  • Hedge Funds Have Never Been More Bullish On BioSpecifics Technologies Corp. (BSTC)
  • Insider Monkey.1d ago
  • Simple Market Timing Strategies That Work - December 04, 2019
  • Zacks.12/04 13:36
  • Looking For Growth? Take A Look At These Biotechnology Stocks
  • Investor's Business Daily.12/02 16:00
  • Here's How P/E Ratios Can Help Us Understand BioSpecifics Technologies Corp. (NASDAQ:BSTC)
  • Simply Wall St..11/22 12:11

More

Industry

Biotechnology & Medical Research
+1.07%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About BSTC

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of Endo International plc (Endo), for injectable collagenase for marketed indications and indications in development. Injectable collagenase clostridium histolyticum is marketed as XIAFLEX (or Xiapex in Europe). The two marketed indications involving its injectable collagenase are Dupuytren's contracture and Peyronie's disease. The other clinical indications for which its collagenase injection has been tested include keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. The Company is evaluating its options for development of additional indications using collagenase.
More

Webull offers BioSpecifics Technologies Corp. (BSTC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.